News & Resources
All resources
Sep 14, 2018
News & Press
ICR Expands Healthcare Practice with Addition of Continuum Health
By ICR
Sep 12, 2018
Blog
Will the Hong Kong Exchange Rival NASDAQ For Biotech IPOs?
By ICR Healthcare
Sep 5, 2018
Blog
The Impact of Total Shareholder Return on Proxy Contest Outcomes
By Dan Mcdermott
Aug 23, 2018
Blog
10 Things Bankers Don’t Tell You About the IPO Road Show
By ICR Healthcare
Aug 22, 2018
Blog
Best Practices in Raising the Profile and Protecting Professional Services Brands
By Christine Hardman and Scott Tangney,
Aug 20, 2018
Blog
Consilium Strategic Communications Acts as PR and IR Advisor to Sensyne Health on Its Successful IPO on London Stock Exchange
By ICR Healthcare
Aug 15, 2018
Blog
An Intro to ESG Research Providers and How to Respond to Their Requests
By Jack Powell
Aug 8, 2018
Blog
Consilium – H1 2018 update
By ICR Healthcare
Aug 1, 2018
Blog
Integrity in PR: Some Sage Advice from Comedian Steve Martin
By Edmond Lococo
Jul 18, 2018
Blog
Presenting Your M&A Deal To Wall Street
By Michael Vallie
Jul 17, 2018
Blog
Consilium Strategic Communications Advises Polyphor on Its Successful CHF 155 Million (C. €130 Million) Fundraise and IPO on the Six Swiss Exchange
By ICR Healthcare
Jul 17, 2018
News & Press
ICR Launches Executive Advisory Corporate Transformation Practice
By ICR
Jul 16, 2018
Blog
Analyzing Share Repurchase Programs
By Allison Malkin
Jul 11, 2018
Blog
Changes to Your IR Plan for Year Two as a Public Company
By Chris Brinzey
Jun 27, 2018
Blog
The Market for Life Sciences IPOs: Crunching the Numbers
By ICR Healthcare
Jun 22, 2018
News & Press
Meituan Appoints ICR as Strategic Communications Advisor
By Edmond Lococo- < Previous posts
- 01
- …
- 52
- 53
- 54
- 55
- 56
- …
- 70
- > Next posts